Clinical Trial Update: Aortic Stenosis and PhosphodiEsterase iNhibition With Aortic Valve Replacement (ASPEN-AVR): A Pilot Study [Phase 4]

View source ↗

Summary

A Phase 4 pilot study evaluating phosphodiesterase inhibition with aortic valve replacement in aortic stenosis was terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Snippet

Sponsor: Washington University School of Medicine | Conditions: Aortic Stenosis | Phase 4 | Status: TERMINATED | Results posted: 2018-09-12